deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT02834260

Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study (IDEXACOR)

Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone: Tolerance and Safety Pilot Study

Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Conditions Congenital Hereditary Stromal Dystrophy of the Cornea Fuchs' Endothelial Dystrophy Keratoconus
Interventions Dexamethasone implant OZURDEX
Updated 9 times since 2017 Last updated: Aug 14, 2019 Started: Jan 10, 2017 Primary completion: Aug 28, 2018 Completion: Aug 8, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Congenital Hereditary Stromal Dystrophy of the Cornea and Fuchs' Endothelial Dystrophy, this trial is completed. The trial is conducted by Centre Hospitalier Universitaire de Saint Etienne and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Mar 2018 · 14 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotRecruiting~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotRecruiting~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshotRecruiting~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Sep 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

▶ Show 4 earlier versions

  1. Jun 2019 — Sep 2019 [monthly]

    Recruiting PHASE2

  2. Jun 2018 — Jun 2019 [monthly]

    Recruiting PHASE2

  3. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  4. Jan 2017 — Mar 2018 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire de Saint Etienne
Data source: Centre Hospitalier Universitaire de Saint Etienne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations